The U.S. Food and Drug Administration (FDA) is aware the United States is experiencing interruptions in the supply of prefilled 0.9% sodium chloride (saline) intravenous (IV) lock/ flush syringes.
The SARS-CoV-2 virus has mutated over time, resulting in genetic variation in the population of circulating viral strains over the course of the COVID-19 pandemic.
Visit https://emergency.cdc.gov/han/2021/han00459.asp for more information.
KCER Release Date: September 29, 2021
One Lot of GLUCAGON Emergency Kit by Eli Lilly: Recall - Due to Loss of Potency
September 16, 2021:
Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised)
July 9, 2021
Lyra SARS-CoV-2 Assay (M120) by Quidel: Class I Recall - Due to Risk of False Negative Results
Company Announcement
July 2, 2021
Company Announcement
May 24, 2021
The following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research: